https://www.selleckchem.com/products/eht-1864.html
LncRNA-AWPPH is highly expressed in serum of CAD patients, which can be reduced by statin therapy, and it may be a potential serum marker for predicting the prognosis of CAD. The aim of the study was to develop a cost-of-illness model that would investigate the costs associated with the management of patients suffering from asthma and severe asthma in the context of acute episodes managed in the emergency room. A total of 795 records were collected between adults and paediatric patients. The data collection form reported an identificat
Curtir
Comentario
Compartilhar
